The Division of Molecular and Cellular Biosciences funded 23 proposals (as of June 22) submitted in response to the Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19) (NSF 20-052) released March 4, 2020 (and now archived). The awards, made through the Rapid Response Research (RAPID) funding mechanism, support research focused on the characterization and modeling of coronavirus SARS-CoV-2, the virus that causes COVID-19. Read more about the RAPID funding mechanism in Chapter II.E.1 (Rapid Response Research) of the Proposal & Award Policies and Procedures Guide (PAPPG).
The proposed research projects will contribute to viral tracking and prevention efforts, provide information on viral transmission and biology of infection, and aid drug development for infection treatment and prevention. Links to these RAPID awards can be found in the table below. More information on funding made by the National Science Foundation to support research on the coronavirus may be found here.
A new Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19) (NSF 20-052) invites non-medical, non-clinical-care research proposals that seek to explore how to model and understand the spread of COVID-19; to inform and educate about the science of virus transmission and prevention; and to encourage the development of processes and actions to address this global challenge.
Proposals may be submitted through the Rapid Response Research (RAPID) funding mechanism as well as through existing funding opportunities.